The immunosuppressive agent mycophenolate is used extensively in kidney transplantation,
yet dosing strategy applied varies markedly from fixed dosing (“one-dose-fits-all”), to …

Mycophenolate mofetil (MMF) was developed with cyclosporine as a fixed-dose
immunosuppressant. More recent data indicate a relationship between mycophenolic acid …

This review describes the state-of-the-art on quality of life (QOL) in kidney transplant (KTx)
recipients. More specifically, posttransplant QOL is compared with the pretransplant …

We studied the incidence, trends and clinical correlates of infections following kidney
transplantation in the United States Renal Data System over the years 1995–2003 in 46,471 …

Glomerulonephritis (GN) is the leading cause of chronic kidney disease among recipients of
renal transplants. Because modern immunosuppressive regimens have reduced the …

While older males are at the highest risk for poor coronavirus disease 2019 (COVID-19)
outcomes, it is not known if this applies to the immunosuppressed recipient of a solid organ …

The primary aim of this study was to fit and test the hypothesized three-factor model of the
Pittsburgh Sleep Quality Index (PSQI) reported by Cole (2006) in renal transplant (RTx) …

For many living with the devastating aftermath of disfiguring facial injuries, extremity
amputations, and other composite tissues defects, conventional reconstruction offers limited …

Although kidney transplantation improves overall quality of life and physical functioning,
improvements of psychological distress are often modest. However, apparent stressors such …

Surveillance of the renal allograft recipient is essential when monitoring renal function to
detect the early onset of rejection and alter therapeutic treatments to treat acute rejection or …